amlodipine has been researched along with Lung Neoplasms in 6 studies
Amlodipine: A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.
amlodipine : A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.
Lung Neoplasms: Tumors or cancer of the LUNG.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To report a case of second-degree atrioventricular block associated with concomitant use of aprepitant and amlodipine." | 8.02 | Exacerbation of atrioventricular block associated with concomitant use of amlodipine and aprepitant in a lung cancer patient: A case report. ( Akiyoshi, T; Fujiwara, Y; Hashimoto, H; Hibino, H; Imaoka, A; Makihara-Ando, R; Makino, Y; Ohe, Y; Ohtani, H; Sakiyama, N; Yamaguchi, M, 2021) |
| " Patients received amlodipine 5 mg daily for grade ≥ 2 bevacizumab-induced hypertension." | 7.78 | Treatment of bevacizumab-induced hypertension by amlodipine. ( Billemont, B; Blanchet, B; Cabanes, L; Camps, S; Coriat, R; Goldwasser, F; Knebelmann, B; Mir, O; Ropert, S, 2012) |
| "To report a case of second-degree atrioventricular block associated with concomitant use of aprepitant and amlodipine." | 4.02 | Exacerbation of atrioventricular block associated with concomitant use of amlodipine and aprepitant in a lung cancer patient: A case report. ( Akiyoshi, T; Fujiwara, Y; Hashimoto, H; Hibino, H; Imaoka, A; Makihara-Ando, R; Makino, Y; Ohe, Y; Ohtani, H; Sakiyama, N; Yamaguchi, M, 2021) |
| " Patients received amlodipine 5 mg daily for grade ≥ 2 bevacizumab-induced hypertension." | 3.78 | Treatment of bevacizumab-induced hypertension by amlodipine. ( Billemont, B; Blanchet, B; Cabanes, L; Camps, S; Coriat, R; Goldwasser, F; Knebelmann, B; Mir, O; Ropert, S, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Hibino, H | 1 |
| Makino, Y | 1 |
| Sakiyama, N | 1 |
| Makihara-Ando, R | 1 |
| Hashimoto, H | 1 |
| Akiyoshi, T | 1 |
| Imaoka, A | 1 |
| Fujiwara, Y | 1 |
| Ohe, Y | 1 |
| Yamaguchi, M | 1 |
| Ohtani, H | 1 |
| Jeon, SY | 1 |
| Lee, NR | 1 |
| Yim, CY | 1 |
| Veeraputhiran, M | 1 |
| Sundermeyer, M | 1 |
| Mir, O | 1 |
| Coriat, R | 1 |
| Ropert, S | 1 |
| Cabanes, L | 1 |
| Blanchet, B | 1 |
| Camps, S | 1 |
| Billemont, B | 1 |
| Knebelmann, B | 1 |
| Goldwasser, F | 1 |
| Huang, J | 1 |
| Wang, T | 1 |
| Huang, Y | 1 |
| Matsumori, A | 1 |
| Nunokawa, Y | 1 |
| Sasayama, S | 1 |
6 other studies available for amlodipine and Lung Neoplasms
| Article | Year |
|---|---|
Exacerbation of atrioventricular block associated with concomitant use of amlodipine and aprepitant in a lung cancer patient: A case report.
Topics: Aged; Amlodipine; Antiemetics; Aprepitant; Atrioventricular Block; Humans; Lung Neoplasms; Male; Mor | 2021 |
Successful re-administration of Pazopanib in a patient with metastatic renal cell carcinoma and a history of Pazopanib-induced nephrotic syndrome: a case report.
Topics: Aged; Amlodipine; Angiogenesis Inhibitors; Antihypertensive Agents; Antineoplastic Agents; Carcinoma | 2019 |
Rhabdomyolysis resulting from pharmacologic interaction between erlotinib and simvastatin.
Topics: Aged; Amlodipine; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Antihypertensiv | 2008 |
Treatment of bevacizumab-induced hypertension by amlodipine.
Topics: Adult; Aged; Amlodipine; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antihypertensiv | 2012 |
Exfoliative esophagitis in a patient with metastatic renal cell carcinoma during sunitinib treatment.
Topics: Amlodipine; Antihypertensive Agents; Antineoplastic Agents; Aspirin; Carcinoma, Renal Cell; Cyclooxy | 2013 |
Nifedipine inhibits activation of transcription factor NF-kappaB.
Topics: Amlodipine; Calcium Channel Blockers; Cell Migration Inhibition; Diltiazem; Dose-Response Relationsh | 2000 |